WJ Financial Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$594K Sell
12,400
-75
-0.6% -$3.22K 0.44% 64
2026
Q1
$458K Buy
12,475
+417
+3% +$19.8K 0.37% 78
2025
Q4
$614K Buy
12,058
+6,909
+134% +$353K 0.55% 60
2025
Q3
$286K Buy
+5,149
New +$301K 0.28% 91

Other funds holding NVO

WJ Financial Advisors's NVO Position: Q2 2026 in Review

WJ Financial Advisors reduced its Novo Nordisk (NVO) stake by 0.6% in Q2 2026, selling an estimated $3.22K and leaving 12,400 shares worth $594K. The position accounts for 0.44% of the portfolio, ranked #64.

WJ Financial Advisors first reported a position in NVO in Q3 2025 and has held it in 4 quarters since. The position peaked at $614K in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • WJ Financial Advisors held 12,400 shares of Novo Nordisk worth $594K as of Q2 2026.
  • WJ Financial Advisors sold 75 Novo Nordisk shares in Q2 2026, an estimated $3.22K.
  • Novo Nordisk made up 0.44% of WJ Financial Advisors's portfolio in Q2 2026, its #64 holding.
  • WJ Financial Advisors first reported a position in Novo Nordisk in Q3 2025 and has held it in 4 quarters since.
  • WJ Financial Advisors's Novo Nordisk position peaked at $614K in Q4 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on WJ Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.